Summary
A small group of acute leukemias can be classified by morphological, cytochemical, or immunological marker analysis neither as acute lymphatic leukemia nor as acute myeloid leukemia. These leukemias are referred to as acute undifferentiated leukemia (AUL) and make up 2%–7% of the acute nonmyeloid leukemias. These leukemias are poorly defined in the literature and are also sometimes referred to as AML-MO. Most of the definitions include in the morphological and cytochemical criteria the expression of myeloid antigens. Here the value of these markers and of other techniques used in the diagnosis of undifferentiated or minimally differentiated leukemia is discussed. More than half of the leukemias that are undifferentiated by morphology and cytochemistry on the light-microscopic level show a positive reaction for myeloperoxidase by electron microscopy, which points to an early myeloid differentiation of those leukemias. Immunological marker analysis in most cases is inconclusive. Most show a positive reaction for CD 13, CD 33 or other myeloid-associated markers. However, in about half of these leukemias co-expression of lymphatic markers is seen. In a small minority, only lymphatic markers are expressed. Cytogenetic abnormalities which are found in these leukemias vary in type, and antigen receptor rearrangements are not lineage specific. Receptor studies, gene expression, and in vitro culture studies may, in the near future, contribute substantially to our knowledge about the commitment of these undifferentiated or minimally differentiated blasts. Recent definitions for AUL and AML-MO based on these different techniques are discussed.
Similar content being viewed by others
References
Adriaansen HJ, Dongen JJM van, Kappers-Klune MC, Hählen K, Veer MB van't, Wijdenes de Bresser JHFM, Holdrinet ACJM, Harthoorn-Lasthuizen EJ, Abels J, Hooykaas H (1990) Terminal deoxynucleotidyl transferase-positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease. Leukemia 4: 404–410
Bain BJ (1990) Leukemia diagnosis, a guide to the FAB classification. Lippincott, Philadelphia
Benedetto P, Mertelsmann R, Szahowski TH (1986) Prognostic significance of terminal deoxynucleotidyl transferase activity in acute nonlymphoblastic leukemia. J Clin Oncol 4: 489–495
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG (1976) Proposals for the classification of the acute leukaemias (FAB cooperative group). Br J Haematol 33: 451–458
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1985) Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med 103: 620–629
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1985) Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7): a report of the French-American-British cooperative group. Ann Intern Med 103: 460–462
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1991) Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO). Br J Haematol 78: 325–329
Bertazzoni U, Brusamolino E, Isernia P, Scovassi J, Torsello S, Lazzarino M, Bernasconi C (1982) Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia. Blood 60: 685–692
Boehm TLJ, Werle A, Drakovsky D (1987) Immunoglobulin heavy chain and T-cell receptor beta and gamma chain gene rearrangements in acute myeloid leukemias. Mol Biol Med 4: 51–62
Cheng GY, Minden MD, Toyonaga B, Mak TW, McCulloch EA (1986) T-cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia. J Exp Med 163: 14–24
Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ, Sawitsky A, Stass S, Weinstein H, Woods WG (1990) Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 8: 813–819
Childs C, Hirsch-Ginsberg C, Walters RD, Andersson BS, Reuben J, Trujilo JM, Cork A, Stass SA, Freireich EJ, Zipf TF (1989) Myeloid surface antigen-positive acute lymphoblastic leukemia (My + ALL): immunophenotypic of ultrastructural, cytogenetic and molecular characteristics. Leukemia 3: 777–783
Del Vecchio L, Schiavone EM, Ferrara F, Pace E, Pardo CL, Pacetti M, Russo M, Cirillo D, Vacca C (1989) Immunodiagnosis of acute leukemia displaying ectopic antigens. Am J Hematol 31: 173–180
Drexler HG, Thiel E, Ludwig W-D (1991) Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 5: 637–645
Foa R, Casorati G, Giubellino MC, Basso G, Shiro T, Pizzolo G, Lauria F, LeFranc M-P, Rabbits TH, Migone N (1987) Rearrangements of immunoglobulin and T-cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia. J Exp Med 165: 879–890
Fontenay M, Flandrin G, Baurman H, Loiseau P, Valensi F, Daniel M-T, Sigaux F (1990) T-cell receptor delta gene rearrangements occur predominantly in immature myeloid leukemias exhibiting lineage promiscuity. Leukemia 4: 100–105
Foon KA, Todd RF (1986) Immunological classification of leukaemia and lymphoma. Blood 68: 1–31
Ganser A, Heil G, Böhm Th, Bartram CR, Raghavachar A, Carbonell F, Hoelzer D (1987) Human acute unclassified leukemia with a unique t(14;17) chromosomal translocation expresses T-lymphoid and myeloid surface antigens after in vitro culture. Blood 69: 271–277
Goorha R, Bunin N, Mirro J, Murphy SB, Cross AH, Behm FG, Quertermous T, Seidman J, Kitchingman GR (1987) Provocative pattern of rearrangements of the genes for the gamma and beta chains of the T-cell receptor in human leukemias. Proc Natl Acad Sci USA 84: 4547–4551
Greaves MF, Chan LC, Furley AJW, Watt SM, Molgaard HV (1986) Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 67: 1–11
Gregg SL, Gail-Peczalska KJ, LeBien TW, Bloomfield CD, Brunning R, Sagawa K (1984) Monoclonal antibody MCS-2 as the marker of phorbol diester-induced myeloid differentiation in acute undifferentiated leukemia. Cancer Res 44: 2724–2730
Ha K, Minden M, Hozumi-Gelfand EW (1984) Immunoglobulin gene rearrangement in acute myelogenous leukemia. Cancer Res 44: 4658–4660
Hara J, Yumura-Yajik K, Tawa A, Ishihara S, Murata M, Terada N, Zumi Y, Champagne E, Takihara Y, Mak TW, Minden M, Kawa-Ha K (1989) Molecular analysis of acute undifferentiated leukemia: two distinct subgroups at the DNA and RNA levels. Blood 74: 1738–1746
Heil G, Ganser A, Raghavachar A, Kurrle E, Hert W, Hoelzer D, Heimpel H (1988) Induction of myeloperoxidase in five cases of acute unclassified leukaemia. Br J Haematol 68: 23–32
Heil G, Gunsilius E, Raghavachar A, Bartram CR, Ganser A, Kurrle E, Aydemir U, Löffler H, Hoelzer D, Thiel E, Heimpel H (1991) Ultrastructural demonstration of peroxidase expression in acute unclassified leukemias: correlation to immunophenotype and treatment outcome. Blood 77: 1305–1312
Imamura N, Kuramoto A (1988) Acute unclassifiable leukaemia in adults, demonstrating myeloid antigens and myeloperoxidase protein. Br J Haematol 69: 427–428
Janossy G, Coustan-Smith E, Campana D (1989) The reliability of cytoplasmic CD 3 and CD 22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases. Leukemia 3: 170–181
Kantarjian HM, Hirsch-Ginsberg C, Yee G, Huh Y, Freirich EJ, Stass S (1990) Mixed-lineage leukemia revisited: acute lymphocytic leukemia with myeloperoxidase-positive blasts by electron microscopy. Blood 76: 808–813
Lee EJ, Pollak A, Leavitt RD, Testa JR, Schiffer CA (1987) Minimally differentiated acute nonlymphocytic leukemia: a distinct entity. Blood 70: 1400–1406
Lee EJ, Yang J, Leavitt RD (1989) The impact of TdT and CD 34 expression on the prognosis of patients with acute myeloid leukemia. Blood 74 [Suppl]: 18
Matutes E, Pombo de Oliveira M, Foroni L, Morilla R, Catovsky D (1988) The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukaemia. Br J Haematol 69: 205–211
Mirro J, Zipf ThF, Pui CH, Kitchingman G, Williams D, Melvin S, Murphy SB, Stass S (1985) Acute mixed-lineage leukemia: clinicopathologic correlations and prognostic significance. Blood 66: 1115–1123
Neame PB, Soamboonsrup P, Browman GP, Meyer RM, Benger A, Wilson WEC, Walker JR, Saeed N, McBride JA (1986) Classifying acute leukemia by immunophenotyping: a combined FAB-immunologic classification of AML. Blood 68: 1355–1362
Norton JD, Campana D, Hoffbrand AV (1987) Rearrangement of immunoglobulin and T-cell antigen receptor genes in acute myeloid leukemia with lymphoid-associated markers. Leukemia 1: 757–761
Ohta M, Saito M, Suda K, Sakamoto S, Kitagawa S, Miura Y, Takaku F (1983) Differentiation of human leukemia cells and its usefulness for clinical diagnosis. Leuk Res 7: 363–374
Oster W, König K, Ludwig W-D, Ganser A, Lindemann A, Mertelsmann R, Herrmann F (1988) Incidence of lineage promiscuity in acute myeloblastic leukemia: diagnostic implications of immunoglobulin and T-cell-receptor gene rearrangement analysis and immunological phenotyping. Leuk Res 12: 887–895
Parreira A, Pombo de Oliveira MS, Matutes E (1988) Terminal deoxynucleotidyl transferase-positive acute myeloid leukemia: an association with immature myeloblastic leukaemia. Br J Haematol 69: 219–224
Pegoraro L, Abraham J, Cooper RA, Levis A, Lange B, Meo P, Rovera G (1980) Differentiation of human leukemias in response to 12-O-tetradecanoyl phorbol-13 acetate in vitro. Blood 55: 859–862
Pui CH, Behm G, Singh B, Rivera GK, Schell MJ, Roberts WM, Crist WM, Mirro J (1990) Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukaemia treated with intensive multiagent chemotherapy. Blood 75: 198–202
Reiffers J, Darmendrail V, Larrue J, Villenave I, Bernard Ph, Boisseau M, Braustet A (1981) Ultrastructural cytochemical prospective study of adult acute lymphoblastic leukemia. Cancer 48: 927–931
Rovigatti U, Mirro J, Kitchingman G, Dahl G, Ochs J, Murphy S, Stass S (1984) Heavy chain immunoglobulin gene rearrangement in acute nonlymphocytic leukemia. Blood 63: 1023–1027
Schachner J, Kantarjian H, Dalton W (1988) Cytogenetic association and prognostic significance of bone marrow blast cell terminal transferase in patients with acute myeloblastic leukemia. Leukemia 2: 667–671
Schoot E van der, Visser FJ, Tetteroo PAT, Borne AEGK von dem (1989) In vitro differentiation of cells of patients with acute undifferentiated leukaemia. Br J Haematol 71: 351–355
Schwarzinger J, Valent P, Köller K (1990) Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia. J Clin Oncol 8: 423–430
Serementis SV, Pelicci PG, Tabilio A, Ubriaco A, Grignani F, Cuttner J, Winchester RJ, Knowles II DM, Dalla-Favera R (1987) High frequency of clonal immunoglobulin or T-cell-receptor gene rearrangements in acute myelogenous leukemia expressing terminal deoxynucleotidyl transferase. J Exp Med 165: 1703–1712
Skolnick T, Schlossmann SF, Griffin JD (1985) Acute undifferentiated leukemia: induction of partial differentiation by phorbol ester. Leuk Res 9: 11–17
Sobol RE, Mick R, Royston J, Davey FR, Ellison RR, Newman R, Cuttner J, Griffin JD, Collins H, Nelson DA, Bloomfield C (1987) Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 316: 1111–1117
Tricot G, Broekaert-van Orshoven A, Hoof A van, Verwilghen RL (1982) Sudan-black B positivity in acute lymphoblastic leukemia. Br J Haematol 51: 615–621
Vaenchenker W, Villeval JL, Tabilio A, Matanis H, Karianakis G, Gruchard J, Henri A, Vernant JP, Roeland H, Breton-Gorius J (1988) Immunophenotype of leukemic blasts with small peroxidase-positive granules detected by electron microscopy. Leukemia 2: 274–281
Vaughan WP, Civin CI, Weisenburger DD, Karp JE, Graham ML, Sanger WG, Grierson HL, Joshi SS, Burke PJ (1988) Acute leukemia expressing the normal human haematopoietic stem cell membrane glycoprotein CD34 (MylO). Leukemia 2: 661–666
Veer MB van't, Kluin-Nelemans JC, Schoot E van der, Putten WLJ van, Adriaansen HJ, Wering ER (1992) Quality assessment of immunological marker analysis in the diagnosis of leukaemia and lymphoma: a multicenter study. Br J Haematol 10: 450–465
Wainscoat JS, Fey MF, Pilkington S, Summers C, Oscier DG (1988) Absence of immunoglobulin and T-cell-receptor gene rearrangements in myelodysplastic syndromes and acute non-lymphocytic leukemias. Am J Hematol 28: 95–97
Wering ER van, Brederoo P, Dijk de Leeuw JHS van, Meulen J van der, Veer MB van't (1990) Electron microscopy: a contribution to further classification of acute unclassifiable childhood leukemia. Blut 60: 291–296
Wiersma SR, Ortega J, Sobel E, Weinberg KJ (1991) Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia in childhood. N Engl J Med 324: 800–808
Williere G, Stockinger H, Koller U, Majdic O, Schnabl E, Lutz D, Bettelheim P, Knapp W (1990) Terminal deoxynucleotidyl transferase and CD7 expression in acute myeloid leukemias are not associated with a high frequency of immunoglobulin and/ or T-cell-receptor gene rearrangements. Leukemia 4: 278–281
Yarden T, Kuang W, Yang-Feng T, Ulbricht A (1987) Human proto-oncogene c-kit: a new cell-surface receptor tyrosine kinase for an unidentified ligand. EMBO J 6: 3341–3349
Youness E, Trujillo JM, Ahearn MJ, McCredie KB, Cork A (1980) Acute unclassified leukemia. A clinical pathological study with diagnostic implications of electron microscopy. Am J Hematol 9: 79–88
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van't Veer, M.B. The diagnosis of acute leukemia with undifferentiated or minimally differentiated blasts. Ann Hematol 64, 161–165 (1992). https://doi.org/10.1007/BF01696217
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01696217